课题基金 / 基金详情

Atherosclerosis:Lipoproteins, cell biology and vascular physiology

Atherosclerosis:Lipoproteins, cell biology and vascular physiology
动脉粥样硬化:脂蛋白、细胞生物学和血管生理学
批准号:
nhmrc : 222722
负责人:
Prof David Celermajer
金额:
$485.06万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Programs
财政年份:
2003
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2003-01-01 至 2007-12-31

项目摘要

项目成果

Prof David Celermajer的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The team comprises internationally recognised experts in basic, clinical and public health applied research in cardiovascular disease, particularly atherosclerosis that is the commonest cause of death in Australia and other developed countries. Over the last decade, improvement in cardiovascular health has been primarily the result of a better understanding on how to control 'bad' (or LDL) cholesterol. The significance of the proposed studies is that, on the one hand, they will provide new information on how 'good' lipoproteins protect us from atherosclerosis. This information can then be used to regulate 'good' cholesterol in a meaningful manner. On the other hand, the proposed studies will provide fundamental insights into how a range of lifestyle factors, physiological processes and pathological conditions relate to both the function of blood vessel-lining cells and susceptibility of individuals to atherosclerosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Atherosclerosis - the key roles of HDL, cell cholesterol metabolism and vascular function
  • 批准号:
    nhmrc : 1037903
  • 项目类别:
    Program Grants
  • 资助金额:
    $545.05万
  • 财政年份:
    2013
  • 负责人:
    Prof David Celermajer
  • 依托单位:
Atherosclerosis - the key roles of HDL, cell cholesterol metabolism and vascular function
  • 批准号:
    nhmrc : GNT1037903
  • 项目类别:
    Programs
  • 资助金额:
    $472.43万
  • 财政年份:
    2013
  • 负责人:
    Prof David Celermajer
  • 依托单位:
Atherosclerosis: Lipoproteins, cell biology and vascular physiology
  • 批准号:
    nhmrc : 482800
  • 项目类别:
    Programs
  • 资助金额:
    $697.58万
  • 财政年份:
    2008
  • 负责人:
    Prof David Celermajer
  • 依托单位:
海外基金